Loading…

Increasing the survival of transverse rectus abdominis musculocutaneous flaps with a Botulinum Toxin-A Injection: A comparison of surgical and chemical flap delay methods

Abstract Background Botulinum Toxin type-A (Btx-A) is a commonly used drug for both cosmetic and therapeutic purposes. The effects of Btx-A on skin and muscle flaps and the related mechanisms have been described previously. In this study, we used a rat transverse rectus abdominis musculocutaneous (T...

Full description

Saved in:
Bibliographic Details
Published in:Journal of plastic, reconstructive & aesthetic surgery reconstructive & aesthetic surgery, 2016-07, Vol.69 (7), p.944-951
Main Authors: Temiz, Gökhan, M.D. Specialist, Yeşiloğlu, Nebil, M.D. Specialist, Şirinoğlu, Hakan, M.D. Specialist, Akpınar, Ali Cem, M.D. Specialist, Sarıcı, Murat, M.D. Specialist, Filinte, Deniz, M.D. Specialist, Filinte, Gaye Taylan, M.D, Bozkurt, Mehmet, M.D
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background Botulinum Toxin type-A (Btx-A) is a commonly used drug for both cosmetic and therapeutic purposes. The effects of Btx-A on skin and muscle flaps and the related mechanisms have been described previously. In this study, we used a rat transverse rectus abdominis musculocutaneous (TRAM) flap model to examine the effects of Btx-A on the skin island, which is perfused by the rectus abdominis muscle according to the angiosome concept. Methods Forty female rats were divided into five groups, including control and sham groups. In the control group, a TRAM flap was raised and sutured back after inserting a silicone sheath underneath the flap. In the sham group, the flap was raised one month after injecting saline into the muscle. In the chemical delay group, the flap was raised one month after injecting 10 IU of Btx-A. In the surgical delay group, the flap was raised two weeks after ligating the cranial epigastric artery. In the surgical and chemical delay group, a Btx-A injection was performed initially, a cranial epigastric artery was ligated after two weeks and a TRAM flap was raised after the first month. In all groups, laser Doppler examination, photographic documentation and analysis of the flap survival rates were performed. In the histopathological evaluation, the diameter of the caudal epigastric vessels, vascular density measurements using CD31 stain and apoptosis rates using the Tunnel method were performed. Results The necrosis ratios, arterial cross-section diameters and microvascular density measurements were significantly superior compared to those of control and sham groups; however, there was no significant difference between the delay groups. There was also no difference in the laser Doppler measurements between the groups and the zones of the TRAM flaps. Conclusion An injection of Btx-A increases muscular circulation and flap survival of TRAM flaps in rats.
ISSN:1748-6815
1878-0539
DOI:10.1016/j.bjps.2016.02.006